☰

Frederick A. Schmitt - Publications

Affiliations: 
University of Kentucky College of Medicine, Lexington, KY, United States 
Tree Info Grants Similar researchers PubMed Report error

218/334 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E. Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37438872 DOI: 10.1002/alz.13382  0.329
2023 Nelson RS, Abner EL, Jicha GA, Schmitt FA, Di J, Wilcock DM, Barber JM, Van Eldik LJ, Katsumata Y, Fardo DW, Nelson PT. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort. Acta Neuropathologica Communications. 11: 89. PMID 37269007 DOI: 10.1186/s40478-023-01576-z  0.334
2023 Stern AM, Van Pelt KL, Liu L, Anderson AK, Ostaszewski B, Mapstone M, O'Bryant S, Petersen ME, Christian BT, Handen BL, Selkoe DJ, Schmitt F, Head E. Plasma NT1-tau and Aβ correlate with age and cognitive function in two large Down syndrome cohorts. Medrxiv : the Preprint Server For Health Sciences. PMID 36945447 DOI: 10.1101/2023.03.10.23287109  0.322
2022 Ashford JW, Schmitt FA, Bergeron MF, Bayley PJ, Clifford JO, Xu Q, Liu X, Zhou X, Kumar V, Buschke H, Dean M, Finkel SI, Hyer L, Perry G. Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. Journal of Alzheimer's Disease : Jad. PMID 35431257 DOI: 10.3233/JAD-220211  0.349
2022 Karanth SD, Katsumata Y, Nelson PT, Fardo DW, McDowell JK, Schmitt FA, Kryscio RJ, Browning SR, Braithwaite D, Arnold SM, Abner EL. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology. Brain : a Journal of Neurology. PMID 35094057 DOI: 10.1093/brain/awac035  0.307
2021 Aschenbrenner AJ, Baksh RA, Benejam B, Beresford-Webb JA, Coppus A, Fortea J, Handen BL, Hartley S, Head E, Jaeger J, Levin J, Loosli SV, Rebillat AS, Sacco S, Schmitt FA, et al. Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12184. PMID 33969175 DOI: 10.1002/dad2.12184  0.335
2021 Hendrix JA, Airey DC, Britton A, Burke AD, Capone GT, Chavez R, Chen J, Chicoine B, Costa ACS, Dage JL, Doran E, Esbensen A, Evans CL, Faber KM, Foroud TM, ... ... Schmitt F, et al. Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. Journal of Clinical Medicine. 10. PMID 33924960 DOI: 10.3390/jcm10091907  0.33
2020 Jiang Y, Li J, Schmitt FA, Jicha GA, Munro NB, Zhao X, Smith CD, Kryscio RJ, Abner EL. Memory-Related Frontal Brainwaves Predict Transition to Mild Cognitive Impairment in Healthy Older Individuals Five Years Before Diagnosis. Journal of Alzheimer's Disease : Jad. PMID 33337367 DOI: 10.3233/JAD-200931  0.317
2020 Van Pelt KL, Koehl L, Caban-Holt A, Anderson-Mooney A, Head E, Schmitt FA. Feasibility of dual-task gait to estimate Alzheimer's related cognitive decline in Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12092. PMID 32875058 DOI: 10.1002/Dad2.12092  0.455
2020 Bardach SH, Barber JM, Schmitt FA, Van Eldik LJ, Boggess MB, Yarbrough M, Jones KC, Jicha GA. The Effectiveness of Community-based Outreach Events for the Promotion of African American Research Participation. Alzheimer Disease and Associated Disorders. PMID 32809985 DOI: 10.1097/Wad.0000000000000404  0.319
2020 Katsumata Y, Abner EL, Karanth S, Teylan MA, Mock CN, Cykowski MD, Lee EB, Boehme KL, Mukherjee S, Kauwe JSK, Kryscio RJ, Schmitt FA, Fardo DW, Nelson PT. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy. Acta Neuropathologica. PMID 32797255 DOI: 10.1007/S00401-020-02211-0  0.361
2020 Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW, Cykowski MD, Jicha GA, Van Eldik LJ, Abner EL. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. Jama Neurology. PMID 32568358 DOI: 10.1001/Jamaneurol.2020.1741  0.328
2019 Moga DC, Beech BF, Abner EL, Schmitt FA, El Khouli RH, Martinez AI, Eckmann L, Huffmyer M, George R, Jicha GA. INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer's Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol. Trials. 20: 806. PMID 31888732 DOI: 10.1186/S13063-019-3993-0  0.426
2019 Rhodus EK, Barber J, Abner EL, Duff DMC, Bardach SH, Caban-Holt A, Lightner D, Rowles GD, Schmitt FA, Jicha GA. Behaviors Characteristic of Autism Spectrum Disorder in a Geriatric Cohort With Mild Cognitive Impairment or Early Dementia. Alzheimer Disease and Associated Disorders. PMID 31517641 DOI: 10.1097/Wad.0000000000000345  0.307
2019 Brown CA, Schmitt FA, Smith CD, Gold BT. Distinct patterns of default mode and executive control network circuitry contribute to present and future executive function in older adults. Neuroimage. PMID 30953834 DOI: 10.1016/J.Neuroimage.2019.03.073  0.374
2019 Jicha GA, Kryscio RJ, Beech BF, Wang W, Lynn BC, Schmitt FA, Coy B, Al-Janabi OM, Abner EL, Nelson PT. O3-10-05: MODULATION OF MICRORNA PATHWAYS BY GEMFIBROZIL IN PREDEMENTIA ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL Alzheimer's & Dementia. 15: P910-P910. DOI: 10.1016/J.Jalz.2019.06.4682  0.312
2019 Jiang Y, Li J, Jicha GA, Smith CD, Munro N, Zhao X, Schmitt FA, Kryscio RJ, Abner EL. PROGNOSIS OF CONVERSION TO MILD COGNITIVE IMPAIRMENT AND TIME TO RELIABLE CHANGES VIA MEMORY-RELATED ELECTROPHYSIOLOGICAL BRAIN SIGNATURES Alzheimer's & Dementia. 15: P157. DOI: 10.1016/J.Jalz.2019.06.4322  0.349
2019 Moga DC, Abner EL, Schmitt FA, Beech BF, Martinez AI, Eckmann L, Huffmyer M, Jicha GA. P4-462: INTERVENTION FOR COGNITIVE RESERVE ENHANCEMENT IN DELAYING THE ONSET OF ALZHEIMER'S SYMPTOMATIC EXPRESSION (INCREASE) STUDY- PROTOCOL AND BASELINE EVALUATION OF PARTICIPANTS Alzheimer's & Dementia. 15: P1480-P1481. DOI: 10.1016/J.Jalz.2019.06.4134  0.383
2019 Sudduth TL, Abner EL, Kryscio RJ, Cheng Q, Goldstein L, Schmitt FA, Al-Janabi OM, Bahrani AA, Nelson PT, Smith CD, Gold BT, Jicha GA, Wilcock DM. P4-186: ASSESSMENT OF PLASMA AND CSF FOR ANGIOGENIC AND INFLAMMATORY PROTEINS IN A CLINICAL COHORT OF PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA REVEAL POTENTIAL BIOMARKERS OF DISEASE SEVERITY Alzheimer's & Dementia. 15: P1347-P1347. DOI: 10.1016/J.Jalz.2019.06.3848  0.402
2019 Barber JM, Abner EL, Boggess B, Caban-Holt AM, Jicha GA, Nelson PT, Schmitt FA. P3-472: SEMANTIC CLUSTERING ON THE C.V.L.T.-II IS REDUCED IN COGNITIVELY INTACT OLDER ADULTS WITH AUTOPSY-CONFIRMED ALZHEIMER'S DISEASE NEUROPATHOLOGIC CHANGE Alzheimer's & Dementia. 15: P1148-P1148. DOI: 10.1016/J.Jalz.2019.06.3507  0.366
2019 Katsumata Y, Abner EL, Kryscio RJ, Schmitt FA, Fardo DW, Nelson PT. P3-438: ASSOCIATIONS BETWEEN TDP-43 PROTEINOPATHY AND COGNITIVE TEST SCORES IN NON-FTLD OLDER ADULTS Alzheimer's & Dementia. 15: P1129-P1130. DOI: 10.1016/J.Jalz.2019.06.3472  0.348
2019 Martinez AI, Beech BF, Abner EL, Jicha GA, Schmitt FA, Eckmann L, Huffmyer M, Moga DC. P2-572: INAPPROPRIATE MEDICATION USE ASSOCIATED WITH LOWER COGNITIVE RESERVE IN INDIVIDUALS WITH PRE-CLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P842-P842. DOI: 10.1016/J.Jalz.2019.06.2981  0.42
2018 Helman AM, Siever M, McCarty KL, Lott IT, Doran E, Abner EL, Schmitt FA, Head E. Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30452414 DOI: 10.3233/Jad-180589  0.432
2018 Miranda AM, Herman M, Cheng R, Nahmani E, Barrett G, Micevska E, Fontaine G, Potier MC, Head E, Schmitt FA, Lott IT, Jiménez-Velázquez IZ, Antonarakis SE, Di Paolo G, Lee JH, et al. Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer's Disease. Cell Reports. 23: 2967-2975. PMID 29874583 DOI: 10.1016/J.Celrep.2018.05.011  0.421
2018 Koehl LM, Walls BD, Brothers SL, Morris SN, Glueck AC, Schmitt FA, Berry DTR, Han DY. Convergent and discriminant validity of the Immediate Postconcussion Assessment and Cognitive Testing Battery (ImPACT) in young athletes. Applied Neuropsychology. Child. 1-11. PMID 29465268 DOI: 10.1080/21622965.2018.1436440  0.366
2018 Broster LS, Li J, Wagner B, Smith CD, Jicha GA, Schmitt FA, Munro N, Haney RH, Jiang Y. Spared behavioral repetition effects in Alzheimer's disease linked to an altered neural mechanism at posterior cortex. Journal of Clinical and Experimental Neuropsychology. 1-16. PMID 29463181 DOI: 10.1080/13803395.2018.1430230  0.385
2018 Lanzillotta C, Tramutola A, Meier S, Schmitt F, Barone E, Perluigi M, Di Domenico F, Abisambra JF. Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models. Journal of Alzheimer's Disease : Jad. 62: 347-359. PMID 29439332 DOI: 10.3233/Jad-170617  0.346
2017 Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmitt FA, Lott IT. Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathologica Communications. 5: 93. PMID 29195510 DOI: 10.1186/S40478-017-0499-4  0.418
2017 Ighodaro ET, Nelson PT, Kukull WA, Schmitt FA, Abner EL, Caban-Holt A, Bardach SH, Hord DC, Glover CM, Jicha GA, Van Eldik LJ, Byrd AX, Fernander A. Challenges and Considerations Related to Studying Dementia in African Americans. Journal of Alzheimer's Disease : Jad. PMID 28731440 DOI: 10.3233/Jad-170242  0.331
2017 Carmona-Iragui M, Balasa M, Benejam B, Alcolea D, Fernández S, Videla L, Sala I, Sánchez-Saudinos MB, Morenas-Rodriguez E, Ribosa-Nogué R, Illán-Gala I, Gonzalez-Ortiz S, Clarimón J, Schmitt F, Powell DK, et al. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28463681 DOI: 10.1016/J.Jalz.2017.03.007  0.406
2017 LeVine H, Spielmann HP, Matveev S, Cauvi FM, Murphy MP, Beckett TL, McCarty K, Lott IT, Doran E, Schmitt F, Head E. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan. Neurobiology of Aging. PMID 28385551 DOI: 10.1016/J.Jalz.2017.06.474  0.346
2017 Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA. Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE). Jama Neurology. PMID 28319243 DOI: 10.1001/Jamaneurol.2016.5778  0.361
2017 Abner EL, Kryscio RJ, Schmitt FA, Fardo DW, Moga DC, Ighodaro ET, Jicha GA, Yu L, Dodge HH, Xiong C, Woltjer RL, Schneider JA, Cairns NJ, Bennett DA, Nelson PT. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Annals of Neurology. PMID 28224671 DOI: 10.1002/Ana.24903  0.369
2017 Li J, Broster LS, Jicha GA, Munro NB, Schmitt FA, Abner E, Kryscio R, Smith CD, Jiang Y. A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging. Alzheimer's Research & Therapy. 9: 3. PMID 28100252 DOI: 10.1186/S13195-016-0229-3  0.425
2017 Brown CA, Johnson NF, Anderson-Mooney AJ, Jicha GA, Shaw LM, Trojanowski JQ, Van Eldik LJ, Schmitt FA, Smith CD, Gold BT. Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease. Neuroimage. Clinical. 13: 106-115. PMID 27942453 DOI: 10.1016/J.Nicl.2016.11.024  0.408
2017 Murphy RR, Wells J, Downing E, Uber M, Han DY, Justusson E, Pettigrew LC, Lee JD, Jicha GA, Schmitt FA, Anderson-Mooney AJ. Detection Of Cognitive Impairment After Acute Ischemic Stroke: Validation Of Brief And More Comprehensive Cognitive Screening Instruments And Implications For Best Practice Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1517  0.329
2016 Dodge HH, Zhu J, Woltjer R, Nelson PT, Bennett DA, Cairns NJ, Fardo DW, Kaye JA, Lyons DE, Mattek N, Schneider JA, Silbert LC, Xiong C, Yu L, Schmitt FA, et al. Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28017827 DOI: 10.1016/J.Jalz.2016.11.003  0.412
2016 Ding X, Kryscio RJ, Turner J, Jicha GA, Cooper G, Caban-Holt A, Schmitt FA, Abner EL. Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial. Journal of the American Geriatrics Society. PMID 27801937 DOI: 10.1111/Jgs.14393  0.348
2016 Lin AL, Powell D, Caban-Holt A, Jicha G, Robertson W, Gold BT, Davis R, Abner E, Wilcock DM, Schmitt FA, Head E. (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia. Neuroimage. Clinical. 11: 728-35. PMID 27330972 DOI: 10.1016/J.Nicl.2016.06.001  0.412
2016 Nelson PT, Trojanowski JQ, Abner EL, Al-Janabi OM, Jicha GA, Schmitt FA, Smith CD, Fardo DW, Wang WX, Kryscio RJ, Neltner JH, Kukull WA, Cykowski MD, Van Eldik LJ, Ighodaro ET. "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). Journal of Neuropathology and Experimental Neurology. PMID 27209644 DOI: 10.1093/Jnen/Nlw033  0.454
2016 Kryscio RJ, Abner EL, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Lou W, Fardo DW, Cooper GE, Schmitt FA. Self-Reported Memory Complaints: A Comparison of Demented and Unimpaired Outcomes. The Journal of Prevention of Alzheimer's Disease. 3: 13-19. PMID 27019842 DOI: 10.1016/J.Jalz.2015.06.312  0.303
2016 Cykowski MD, Takei H, Van Eldik LJ, Schmitt FA, Jicha GA, Powell SZ, Nelson PT. Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons. Journal of Neuropathology and Experimental Neurology. PMID 26971127 DOI: 10.1093/Jnen/Nlw014  0.412
2016 Anderson-Mooney AJ, Schmitt FA, Head E, Lott IT, Heilman KM. Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms. Brain and Cognition. 104: 48-57. PMID 26930369 DOI: 10.1016/J.Bandc.2016.02.007  0.455
2016 Smith CD, Johnson ES, Van Eldik LJ, Jicha GA, Schmitt FA, Nelson PT, Kryscio RJ, Murphy RR, Wellnitz CV. Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease. Brain and Behavior. e00438. PMID 26925303 DOI: 10.1002/Brb3.438  0.423
2016 Jiang Y, Huang H, Abner E, Broster LS, Jicha GA, Schmitt FA, Kryscio R, Andersen A, Powell D, Van Eldik L, Gold BT, Nelson PT, Smith C, Ding M. Alzheimer's Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States. Frontiers in Aging Neuroscience. 8: 15. PMID 26903858 DOI: 10.3389/Fnagi.2016.00015  0.433
2016 Ighodaro ET, Abner EL, Fardo DW, Lin AL, Katsumata Y, Schmitt FA, Kryscio RJ, Jicha GA, Neltner JH, Monsell SE, Kukull WA, Moser DK, Appiah F, Bachstetter AD, Van Eldik LJ, et al. Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26738751 DOI: 10.1177/0271678X15621574  0.407
2016 Head E, Fitch JC, Davis PR, Wilcock DM, Schmitt FA. O3-04-05: Frontal Cortex Microhemorrhages in Aging Adults with Down Syndrome: A Potentially Important Contributor to Alzheimer's Disease Pathogenesis Alzheimer's & Dementia. 12: P293-P293. DOI: 10.1016/J.Jalz.2016.06.528  0.346
2015 Neltner JH, Abner EL, Jicha GA, Schmitt FA, Patel E, Poon LW, Marla G, Green RC, Davey A, Johnson MA, Jazwinski SM, Kim S, Davis D, Woodard JL, Kryscio RJ, et al. Brain pathologies in extreme old age. Neurobiology of Aging. PMID 26597697 DOI: 10.1016/J.Neurobiolaging.2015.10.009  0.395
2015 Wilcock DM, Schmitt FA, Head E. Cerebrovascular contributions to aging and Alzheimer disease in down syndrome. Biochimica Et Biophysica Acta. PMID 26593849 DOI: 10.1016/J.Bbadis.2015.11.007  0.453
2015 Wilcock DM, Hurban J, Helman AM, Sudduth TL, McCarty KL, Beckett TL, Ferrell JC, Murphy MP, Abner EL, Schmitt FA, Head E. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease. Neurobiology of Aging. 36: 2468-74. PMID 26103884 DOI: 10.1016/J.Neurobiolaging.2015.05.016  0.402
2015 Ighodaro ET, Jicha GA, Schmitt FA, Neltner JH, Abner EL, Kryscio RJ, Smith CD, Duplessis T, Anderson S, Patel E, Bachstetter A, Van Eldik LJ, Nelson PT. Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature. Journal of Neuropathology and Experimental Neurology. 74: 642-52. PMID 26083567 DOI: 10.1097/Nen.0000000000000204  0.407
2015 Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ, Patel E, Abner EL, Kryscio RJ, Nelson PT. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathologica Communications. 3: 32. PMID 26001591 DOI: 10.1186/S40478-015-0209-Z  0.436
2015 Cummings JL, Isaacson RS, Schmitt FA, Velting DM. A practical algorithm for managing Alzheimer's disease: what, when, and why? Annals of Clinical and Translational Neurology. 2: 307-23. PMID 25815358 DOI: 10.1002/Acn3.166  0.435
2015 Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, ... ... Schmitt F, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/S00401-015-1407-2  0.422
2015 Katsumata Y, Mathews M, Abner EL, Jicha GA, Caban-Holt A, Smith CD, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW. Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort. Dementia and Geriatric Cognitive Disorders. 39: 215-27. PMID 25613081 DOI: 10.1159/000370108  0.331
2015 McBride JC, Zhao X, Munro NB, Jicha GA, Schmitt FA, Kryscio RJ, Smith CD, Jiang Y. Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease. Neuroimage. Clinical. 7: 258-65. PMID 25610788 DOI: 10.1016/J.Nicl.2014.12.005  0.409
2015 Di Domenico F, Pupo G, Mancuso C, Barone E, Paolini F, Arena A, Blarzino C, Schmitt FA, Head E, Butterfield DA, Perluigi M. Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 1107-20. PMID 25391381 DOI: 10.3233/Jad-141254  0.341
2015 Scheff SW, Price DA, Ansari MA, Roberts KN, Schmitt FA, Ikonomovic MD, Mufson EJ. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 43: 1073-90. PMID 25147118 DOI: 10.3233/Jad-141518  0.429
2015 Abner EL, Ding X, Caban-Holt AM, Schmitt FA, Kryscio RJ. P3-262: Comorbid subjective cognitive decline and sleep apnea significantly increase the risk of incident dementia: Results from the prevention of Alzheimer's disease with vitamin e and selenium study Alzheimer's & Dementia. 11: P733-P733. DOI: 10.1016/J.Jalz.2015.06.1635  0.403
2014 Head E, Schmitt FA. Con: are we ready to translate Alzheimer's disease-modifying therapies to people with down syndrome? Alzheimer's Research & Therapy. 6: 61. PMID 25478026 DOI: 10.1186/S13195-014-0061-6  0.411
2014 Kryscio RJ, Abner EL, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Self-reported memory complaints: implications from a longitudinal cohort with autopsies. Neurology. 83: 1359-65. PMID 25253756 DOI: 10.1212/Wnl.0000000000000856  0.34
2014 Martin SB, Dowling AL, Lianekhammy J, Lott IT, Doran E, Murphy MP, Beckett TL, Schmitt FA, Head E. Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 42: 767-75. PMID 24927707 DOI: 10.3233/Jad-140795  0.405
2014 Gold BT, Zhu Z, Brown CA, Andersen AH, LaDu MJ, Tai L, Jicha GA, Kryscio RJ, Estus S, Nelson PT, Scheff SW, Abner E, Schmitt FA, Van Eldik LJ, Smith CD. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Neurobiology of Aging. 35: 2263-71. PMID 24866404 DOI: 10.1016/J.Neurobiolaging.2014.04.030  0.385
2014 Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Frontiers in Genetics. 5: 88. PMID 24795750 DOI: 10.3389/Fgene.2014.00088  0.417
2014 Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, ... ... Schmitt FA, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathologica. 127: 825-43. PMID 24770881 DOI: 10.1007/S00401-014-1282-2  0.341
2014 Mathews M, Abner E, Kryscio R, Jicha G, Cooper G, Smith C, Caban-Holt A, Schmitt FA. Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 675-83. PMID 24656850 DOI: 10.1016/J.Jalz.2013.11.007  0.388
2014 McBride JC, Zhao X, Munro NB, Smith CD, Jicha GA, Hively L, Broster LS, Schmitt FA, Kryscio RJ, Jiang Y. Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease. Computer Methods and Programs in Biomedicine. 114: 153-63. PMID 24598317 DOI: 10.1016/J.Cmpb.2014.01.019  0.443
2014 Powell D, Caban-Holt A, Jicha G, Robertson W, Davis R, Gold BT, Schmitt FA, Head E. Frontal white matter integrity in adults with Down syndrome with and without dementia. Neurobiology of Aging. 35: 1562-9. PMID 24582640 DOI: 10.1016/J.Neurobiolaging.2014.01.137  0.404
2014 Abner EL, Nelson PT, Schmitt FA, Browning SR, Fardo DW, Wan L, Jicha GA, Cooper GE, Smith CD, Caban-Holt AM, Van Eldik LJ, Kryscio RJ. Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort. Dementia and Geriatric Cognitive Disorders. 37: 294-306. PMID 24401791 DOI: 10.1159/000355478  0.413
2014 Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Hammack E, Kukull WA, Brenowitz WD, Van Eldik LJ, Nelson PT. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain : a Journal of Neurology. 137: 255-67. PMID 24271328 DOI: 10.1093/Brain/Awt318  0.352
2014 Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. Journal of Alzheimer's Disease : Jad. 39: 691-702. PMID 24270205 DOI: 10.3233/Jad-131880  0.452
2014 Rannikmäe K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, Al-Shahi Salman R, Sudlow CL. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 300-5. PMID 24163429 DOI: 10.1136/Jnnp-2013-306485  0.308
2014 Powell D, Head E, Caban-Holt A, Jicha GA, Robertson W, Davis R, Davis PR, Gold BT, Schmitt FA. P2-015: LOSSES IN FRONTAL WHITE MATTER INTEGRITY IN ADULTS WITH DOWN SYNDROME WITH AND WITHOUT DEMENTIA Alzheimer's & Dementia. 10: P475-P475. DOI: 10.1016/J.Jalz.2014.05.688  0.316
2013 Farlow MR, Schmitt F, Aarsland D, Grossberg GT, Somogyi M, Meng X. Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia. Dementia and Geriatric Cognitive Disorders Extra. 3: 281-90. PMID 24174923 DOI: 10.1159/000351861  0.469
2013 Broster LS, Li J, Smith CD, Jicha GA, Schmitt FA, Jiang Y. Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology. 35: 946-59. PMID 24074205 DOI: 10.1080/13803395.2013.838942  0.405
2013 Mathews M, Abner E, Caban-Holt A, Dennis BC, Kryscio R, Schmitt F. Quality of education and memory test performance in older men: The New York University paragraph recall test normative data Current Alzheimer Research. 10: 776-783. PMID 23906000 DOI: 10.2174/15672050113109990140  0.319
2013 Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathologica. 126: 161-77. PMID 23864344 DOI: 10.1007/S00401-013-1154-1  0.41
2013 Mathews M, Abner E, Caban-Holt A, Kryscio R, Schmitt F. CERAD practice effects and attrition bias in a dementia prevention trial. International Psychogeriatrics. 25: 1115-23. PMID 23570673 DOI: 10.1017/S1041610213000367  0.412
2013 Kryscio RJ, Abner EL, Lin Y, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 35: 823-32. PMID 23507772 DOI: 10.3233/Jad-122146  0.38
2013 Scheff SW, Price DA, Schmitt FA, Roberts KN, Ikonomovic MD, Mufson EJ. Synapse stability in the precuneus early in the progression of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 599-609. PMID 23478309 DOI: 10.3233/Jad-122353  0.44
2013 Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, et al. Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 151-9. PMID 23375564 DOI: 10.1016/J.Jalz.2012.08.008  0.402
2013 Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM. Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiology of Aging. 34: 1051-9. PMID 23062700 DOI: 10.1016/J.Neurobiolaging.2012.09.012  0.377
2013 Jicha G, Panuganti P, Abner E, Nelson P, Schmitt F, Kryscio R, Van Eldik L, Smith C. P2-118: Neuopathologic substrate of clinically evident, asymmetric, hippocampal atrophy in Alzheimer's disease Alzheimer's & Dementia. 9: P389-P389. DOI: 10.1016/J.Jalz.2013.05.762  0.384
2013 Jicha G, Nelson P, Fardo D, Kryscio R, Schmitt F, Smith C, Neltner J, Van Eldik L, Kukull W, Abner E. P1-397: Vascular neuropathology in dementia patients receiving antipsychotic therapy Alzheimer's & Dementia. 9: P303-P303. DOI: 10.1016/J.Jalz.2013.05.624  0.313
2013 Abner E, Schmitt F, Kryscio R, Jicha G, Cooper G, Smith C, Fardo D, Van Eldik L, Gooding L. P4-241: Early-to mid-life formal training in music is associated with improved late-life semantic and episodic memory among cognitively normal older adults Alzheimer's & Dementia. 9: P793-P793. DOI: 10.1016/J.Jalz.2013.05.1633  0.313
2013 Kryscio R, Abner E, Fardo D, Nelson P, Jicha G, Smith C, Cooper G, Caban-Holt A, Van Eldik L, Schmitt F. P4-178: Self-reported memory decline predicts mild cognitive impairment and dementia Alzheimer's & Dementia. 9: P771-P771. DOI: 10.1016/J.Jalz.2013.05.1569  0.379
2013 Abner E, Nelson P, Schmitt F, Browning S, Fardo D, Wan L, Jicha G, Cooper G, Smith C, Caban-Holt A, Van Eldik L, Kryscio R. O5-05-04: Self-reported head injury and risk of cognitive impairment and Alzheimer's-type pathology in a longitudinal Alzheimer's disease center cohort Alzheimer's & Dementia. 9: P838-P838. DOI: 10.1016/J.Jalz.2013.04.496  0.408
2012 Head E, Powell D, Gold BT, Schmitt FA. Alzheimer's Disease in Down Syndrome. European Journal of Neurodegenerative Disease. 1: 353-364. PMID 25285303  0.379
2012 Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA, Crowley JJ. Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial. Trials. 13: 217. PMID 23171483 DOI: 10.1186/1745-6215-13-217  0.357
2012 Neltner JH, Abner EL, Schmitt FA, Denison SK, Anderson S, Patel E, Nelson PT. Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. Journal of Neuropathology and Experimental Neurology. 71: 1075-85. PMID 23147505 DOI: 10.1097/Nen.0B013E3182768De4  0.339
2012 Kruger TM, Abner EL, Mendiondo M, Schmitt FA, Smith CD, Jicha GA. Differential reports of pain and depression differentiate mild cognitive impairment from cognitively intact elderly participants. Journal of Geriatric Psychiatry and Neurology. 25: 107-12. PMID 22689703 DOI: 10.1177/0891988712445097  0.32
2012 Caban-Holt A, Abner E, Kryscio RJ, Crowley JJ, Schmitt FA. Age-expanded normative data for the Ruff 2&7 Selective Attention Test: evaluating cognition in older males. The Clinical Neuropsychologist. 26: 751-68. PMID 22651854 DOI: 10.1080/13854046.2012.690451  0.397
2012 Abner EL, Kryscio RJ, Cooper GE, Fardo DW, Jicha GA, Mendiondo MS, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Mild cognitive impairment: statistical models of transition using longitudinal clinical data. International Journal of Alzheimer's Disease. 2012: 291920. PMID 22536535 DOI: 10.1155/2012/291920  0.42
2012 Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, Cooper G, Mendiondo M, Danner DD, Van Eldik LJ, Caban-Holt A, Lovell MA, Kryscio RJ. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Current Alzheimer Research. 9: 724-33. PMID 22471862 DOI: 10.2174/156720512801322591  0.373
2012 Cenini G, Dowling AL, Beckett TL, Barone E, Mancuso C, Murphy MP, Levine H, Lott IT, Schmitt FA, Butterfield DA, Head E. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica Et Biophysica Acta. 1822: 130-8. PMID 22009041 DOI: 10.1016/J.Bbadis.2011.10.001  0.349
2012 Jicha GA, Abner EL, Schmitt FA, Kryscio RJ, Riley KP, Cooper GE, Stiles N, Mendiondo MS, Smith CD, Van Eldik LJ, Nelson PT. Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiology of Aging. 33: 622.e1-622.e16. PMID 21507528 DOI: 10.1016/J.Neurobiolaging.2011.02.018  0.482
2012 Singhal D, Abner E, Schmitt F, Nelson P, Jicha G. Antipsychotic Use Is Not Associated with an Increased Burden of Cerebrovascular Pathology at Autopsy (S04.004) Neurology. 78: S04.004-S04.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S04.004  0.39
2012 Singhal D, Hack N, Abner E, Schmitt F, Nelson P, Jicha G. Examining Instability and Reversion in the Diagnosis of Mild Cognitive Impairment (P04.207) Neurology. 78: P04.207-P04.207. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P04.207  0.371
2012 Metcalf A, Abner E, Schmitt F, Kryscio R, Stiles N, Jicha G. Frontal Release Signs Predict Decline in Subjects with Intact Cognition and Mild Cognitive Impairment (P01.082) Neurology. 78: P01.082-P01.082. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.082  0.366
2012 Abner E, Kryscio R, Caban-Holt A, Mathews M, Schmitt F. P2-269: Influence of repeated assessments on the CERAD T-score, a global measure of cognition Alzheimer's & Dementia. 8: P356-P357. DOI: 10.1016/J.Jalz.2012.05.977  0.325
2012 Head E, Davis R, Caban-Holt A, Dennis B, Jicha G, Powell D, Abner E, Dowling AL, Gold B, Wyss-Coray T, Schmitt F. P2-267: A longitudinal study of aging and the development of Alzheimer's disease in people with Down syndrome Alzheimer's & Dementia. 8: P355-P356. DOI: 10.1016/J.Jalz.2012.05.975  0.394
2012 Jicha G, Singhal D, Hack N, Abner E, Schmitt F, Kryscio R. O2-13-05: Reversion from mild cognitive impairment to cognitively intact is associated with medically reversible causes for cognitive decline rather than overt instability in the diagnosis of mild cognitive impairment Alzheimer's & Dementia. 8: P263-P263. DOI: 10.1016/J.Jalz.2012.05.700  0.361
2012 Abner E, Schmitt F, Caban-Holt A, Dennis B, Mathews M, Cooper G, Jicha G, Ranseen J, Mendiondo M, Kryscio R. P1-108: Dual cognitive screening for dementia: Preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADViSE) trial Alzheimer's & Dementia. 8: P144-P144. DOI: 10.1016/J.Jalz.2012.05.385  0.393
2011 Ferris SH, Schmitt FA, Saxton J, Richardson S, Mackell J, Sun Y, Xu Y. Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease. Alzheimer's Research & Therapy. 3: 22. PMID 21689411 DOI: 10.1186/Alzrt84  0.383
2011 Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain : a Journal of Neurology. 134: 1506-18. PMID 21596774 DOI: 10.1093/Brain/Awr053  0.384
2011 Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW. Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathologica. 121: 571-87. PMID 21516511 DOI: 10.1007/S00401-011-0826-Y  0.446
2011 Riley KP, Jicha GA, Davis D, Abner EL, Cooper GE, Stiles N, Smith CD, Kryscio RJ, Nelson PT, Van Eldik LJ, Schmitt FA. Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. Journal of Alzheimer's Disease : Jad. 25: 707-17. PMID 21498903 DOI: 10.3233/Jad-2011-102133  0.469
2011 Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha GA, Lin Y, Neltner JM, Smith CD, Van Eldik LJ, Nelson PT. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction? Journal of Alzheimer's Disease : Jad. 25: 445-53. PMID 21471646 DOI: 10.3233/Jad-2011-101980  0.426
2011 Alva G, Grossberg GT, Schmitt FA, Meng X, Olin JT. Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. International Journal of Geriatric Psychiatry. 26: 356-63. PMID 21312297 DOI: 10.1002/Gps.2534  0.423
2011 Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 24: 547-57. PMID 21297265 DOI: 10.3233/Jad-2011-101782  0.46
2011 Head E, Doran E, Nistor M, Hill M, Schmitt FA, Haier RJ, Lott IT. Plasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome. Journal of Alzheimer's Disease : Jad. 23: 399-409. PMID 21116050 DOI: 10.3233/Jad-2010-101335  0.392
2010 Grossberg GT, Schmitt FA, Xiangyi Meng, Tekin S, Olin J. Effects of transdermal rivastigmine on ADAS-Cog items in mild-to-moderate Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias. 25: 627-633. PMID 21131668 DOI: 10.1177/1533317510385808  0.418
2010 McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 482-93. PMID 21044778 DOI: 10.1016/J.Jalz.2009.09.004  0.436
2010 Schmitt FA, Farlow MR, Meng X, Tekin S, Olin JT. Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia. Cns Neuroscience & Therapeutics. 16: 330-6. PMID 20950329 DOI: 10.1111/J.1755-5949.2010.00182.X  0.402
2010 Nelson PT, Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith CD, Van Eldik LJ, Markesbery WR. Association between male gender and cortical Lewy body pathology in large autopsy series. Journal of Neurology. 257: 1875-81. PMID 20563821 DOI: 10.1007/S00415-010-5630-4  0.372
2010 Schmitt FA, Aarsland D, Brønnick KS, Meng X, Tekin S, Olin JT. Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items. American Journal of Alzheimer's Disease and Other Dementias. 25: 407-13. PMID 20392860 DOI: 10.1177/1533317510367486  0.427
2010 Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. Journal of Neurology. 257: 359-66. PMID 19795154 DOI: 10.1007/S00415-009-5324-Y  0.448
2010 Jicha GA, Schmitt FA, Abner E, Nelson PT, Cooper GE, Smith CD, Markesbery WR. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiology of Aging. 31: 1805-13. PMID 19026468 DOI: 10.1016/J.Neurobiolaging.2008.09.017  0.369
2010 Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Davis DG, Poduska JW, Patel E, Mendiondo MS, Markesbery WR. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathology (Zurich, Switzerland). 20: 66-79. PMID 19021630 DOI: 10.1111/J.1750-3639.2008.00244.X  0.463
2010 Kruger TM, Abner E, Schmitt FA, Jicha GA. O1-05-04: Pain and depression in normal cognitive aging and mild cognitive impairment Alzheimer's & Dementia. 6: S79-S79. DOI: 10.1016/J.Jalz.2010.05.236  0.334
2009 Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, Peterson SL, Schmitt FA, Markesbery WR, Liu Q, Crook JE, Younkin SG, Bu G, Estus S. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Molecular Neurodegeneration. 4: 46. PMID 19889229 DOI: 10.1186/1750-1326-4-46  0.37
2009 Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Disease and Associated Disorders. 23: 260-7. PMID 19812469 DOI: 10.1097/Wad.0B013E31819Cb760  0.392
2009 Nelson PT, Kryscio RJ, Jicha GA, Abner EL, Schmitt FA, Xu LO, Cooper G, Smith CD, Markesbery WR. Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology. 73: 1127-33. PMID 19805729 DOI: 10.1212/Wnl.0B013E3181Bacf9E  0.393
2009 Schmitt FA, Saxton JA, Xu Y, McRae T, Sun Y, Richardson S, Li H. A brief instrument to assess treatment response in the patient with advanced alzheimer disease Alzheimer Disease and Associated Disorders. 23: 377-383. PMID 19571727 DOI: 10.1097/Wad.0B013E3181Ac9Cc1  0.399
2009 Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Santacruz K, Smith CD, Patel E, Markesbery WR. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 68: 774-84. PMID 19535994 DOI: 10.1097/Nen.0B013E3181Aacbe9  0.411
2009 Markesbery WR, Jicha GA, Liu H, Schmitt FA. Lewy body pathology in normal elderly subjects. Journal of Neuropathology and Experimental Neurology. 68: 816-22. PMID 19535990 DOI: 10.1097/Nen.0B013E3181Ac10A7  0.411
2009 Price JL, McKeel DW, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging. 30: 1026-36. PMID 19376612 DOI: 10.1016/J.Neurobiolaging.2009.04.002  0.493
2009 Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR. Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. Journal of Alzheimer's Disease : Jad. 16: 29-34. PMID 19158418 DOI: 10.3233/Jad-2009-0926  0.466
2009 Hoffmann M, Schmitt F, Bromley E. Comprehensive cognitive neurological assessment in stroke. Acta Neurologica Scandinavica. 119: 162-71. PMID 19053949 DOI: 10.1111/J.1600-0404.2008.01101.X  0.303
2009 Nelson PT, Abner EL, Scheff SW, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Patel E, Markesbery WR. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neuroscience Letters. 450: 336-9. PMID 19010392 DOI: 10.1016/J.Neulet.2008.11.006  0.421
2009 Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, Davis GJ, Keller JN, Jicha GA, Davis D, Wang-Xia W, Hartman A, Katz DG, Markesbery WR. Human cerebral neuropathology of Type 2 diabetes mellitus. Biochimica Et Biophysica Acta. 1792: 454-69. PMID 18789386 DOI: 10.1016/J.Bbadis.2008.08.005  0.305
2009 Jicha GA, Abner E, Schmitt FA, Markesbery WR. P4-096: Preclinical Alzheimer's disease cannot be reliably identified in the antemortem setting using standard clinical and neuropsychological test measures Alzheimer's & Dementia. 5: P459-P459. DOI: 10.1016/J.Jalz.2009.04.865  0.383
2009 Schmitt FA, Kryscio RJ, Xu L, Mendiondo M, Caban-Holt A, Abner E, Runyons C, Markesbery WR. P1-277: Effects of repeated screening and potential impact on AD prevention trial design: The antioxidant AD prevention (PREADVISE) trial Alzheimer's & Dementia. 5: P258-P258. DOI: 10.1016/J.Jalz.2009.04.285  0.338
2008 Dassel KB, Schmitt FA. The impact of caregiver executive skills on reports of patient functioning. The Gerontologist. 48: 781-92. PMID 19139251 DOI: 10.1093/Geront/48.6.781  0.413
2008 Jicha GA, Abner E, Carr S, Schmitt F, Markesbery W. P1-162: Mild cognitive impairment in two distinct clinical populations: Acceptance of diagnosis, medical causes, and cognitive profiles Alzheimer's & Dementia. 4: T255-T255. DOI: 10.1016/J.Jalz.2008.05.750  0.369
2008 Schmitt FA, Caban-Holt A, Abner EL, Runyons C, Kryscio R, Mendiondo M, Markesbery WR. P4-393: Memory screening validation for Alzheimer prevention trials: The prevention of Alzheimer's disease by vitamin E and selenium (PREADVISE) study Alzheimer's & Dementia. 4: T789-T790. DOI: 10.1016/J.Jalz.2008.05.2463  0.376
2008 Scheff SW, Price DA, Schmitt FA, Mufson EJ. P4-158: Preservation of synaptic numbers in the precuneus associated with mild cognitive impairment and mild-to-moderate Alzheimer's disease Alzheimer's & Dementia. 4: T716-T717. DOI: 10.1016/J.Jalz.2008.05.2225  0.43
2008 Jicha GA, Abner E, Schmitt FA, Nelson PT, Davis D, Markesbery WR. P4-155: Preclinical Alzheimer's disease in a large autopsy series of longitudinally studied, cognitively normal control subjects Alzheimer's & Dementia. 4: T715-T716. DOI: 10.1016/J.Jalz.2008.05.2222  0.433
2008 Mendiondo MS, Kryscio RJ, Abner EL, Caban-Holt AM, Runyons C, Markesbery WR, Schmitt FA. P3-159: Practice effects: Factors associated with repeated memory impairment screen scores in the antioxidant Alzheimer's disease prevention (PREADVISE) trial Alzheimer's & Dementia. 4: T566-T567. DOI: 10.1016/J.Jalz.2008.05.1725  0.388
2007 Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H, Fillit H. Should older adults be screened for dementia? It is important to screen for evidence of dementia! Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 75-80. PMID 19595920 DOI: 10.1016/J.Jalz.2007.03.005  0.372
2007 Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, Abner EL, Markesbery WR. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. Journal of Neuropathology and Experimental Neurology. 66: 1136-46. PMID 18090922 DOI: 10.1097/Nen.0B013E31815C5Efb  0.471
2007 Weycker D, Taneja C, Edelsberg J, Erder MH, Schmitt FA, Setyawan J, Oster G. Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Current Medical Research and Opinion. 23: 1187-97. PMID 17519086 DOI: 10.1185/030079907X188071  0.373
2007 Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR. The HIV Dementia Scale: predictive power in mild dementia and HAART. Journal of the Neurological Sciences. 260: 11-5. PMID 17482212 DOI: 10.1016/J.Jns.2006.03.023  0.303
2007 Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, Markesbery WR. Brain structural alterations before mild cognitive impairment. Neurology. 68: 1268-73. PMID 17438217 DOI: 10.1212/01.Wnl.0000259542.54830.34  0.324
2007 Bottiggi KA, Salazar JC, Yu L, Caban-Holt AM, Ryan M, Schmitt FA. Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 15: 357-9. PMID 17384320 DOI: 10.1097/Jgp.0B013E31802Dd354  0.377
2007 Schmitt F, Ryan M, Cooper G. A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease. Expert Opinion On Drug Metabolism & Toxicology. 3: 135-41. PMID 17269900 DOI: 10.1517/17425255.3.1.135  0.405
2007 Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Markesbery WR. Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiology of Aging. 28: 1075-87. PMID 16774798 DOI: 10.1016/J.Neurobiolaging.2006.05.018  0.32
2007 Salazar JC, Schmitt FA, Yu L, Mendiondo MM, Kryscio RJ. Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. Statistics in Medicine. 26: 568-80. PMID 16345024 DOI: 10.1002/Sim.2437  0.396
2007 Schmitt FA, Kryscio RJ, Caban-Holt A, Abner EL, Runyons C, Mendiondo M, Bottigi K, Markesbery WR. P-118: Concordance of MIS and CERAD screening in the preadvise antioxidant AD prevention trial Alzheimer's & Dementia. 3: S136-S136. DOI: 10.1016/J.Jalz.2007.04.182  0.323
2007 Schmitt FA, Kryscio RJ, Abner EL, Mendiondo MS, Runyons C, Caban-Holt A, Markesbery WR. P-200: Factors associated with practice effects and decline in MIS scores in the preadvise antioxidant Alzheimer's disease prevention trial Alzheimer's & Dementia. 3: S162-S162. DOI: 10.1016/J.Jalz.2007.04.163  0.388
2006 Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H. Should older adults be screened for dementia? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 76-85. PMID 19595860 DOI: 10.1016/J.Jalz.2006.02.005  0.344
2006 Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Disease and Associated Disorders. 20: S124-38. PMID 17135806 DOI: 10.1097/01.Wad.0000213878.47924.44  0.331
2006 Feldman HH, Schmitt FA, Olin JT. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Alzheimer Disease and Associated Disorders. 20: 263-8. PMID 17132971 DOI: 10.1097/01.Wad.0000213859.35355.59  0.407
2006 Schmitt FA, van Dyck CH, Wichems CH, Olin JT. Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis. Alzheimer Disease and Associated Disorders. 20: 255-62. PMID 17132970 DOI: 10.1097/01.Wad.0000213860.35355.D4  0.424
2006 Bottiggi KA, Salazar JC, Yu L, Caban-Holt AM, Ryan M, Mendiondo MS, Schmitt FA. Long-term cognitive impact of anticholinergic medications in older adults. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 980-4. PMID 17068321 DOI: 10.1097/01.Jgp.0000224619.87681.71  0.342
2006 Schmitt FA, Wichems CH. A systematic review of assessment and treatment of moderate to severe Alzheimer's disease. Primary Care Companion to the Journal of Clinical Psychiatry. 8: 158-9. PMID 16912819 DOI: 10.4088/Pcc.V08N0306  0.41
2006 Mitchell DB, Schmitt FA. Short- and long-term implicit memory in aging and Alzheimer's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 13: 611-35. PMID 16887792 DOI: 10.1080/13825580600697616  0.408
2006 van Dyck CH, Schmitt FA, Olin JT. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 428-37. PMID 16670247 DOI: 10.1097/01.Jgp.0000203151.17311.38  0.429
2006 Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Archives of Neurology. 63: 49-54. PMID 16401736 DOI: 10.1001/Archneur.63.1.49  0.383
2006 Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Neuropathologic substrate of mild cognitive impairment. Archives of Neurology. 63: 38-46. PMID 16401735 DOI: 10.1001/Archneur.63.1.38  0.396
2006 Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 27: 1372-84. PMID 16289476 DOI: 10.1016/J.Neurobiolaging.2005.09.012  0.376
2006 Bottiggi KA, Mendiondo M, Mattingly M, Smith C, Cooper G, Jicha G, Schmitt F. The Influence of Literacy on Cognitive Functioning in Unimpaired Older Adults, Mild Cognitive Impairment, and Dementia Alzheimer Disease & Associated Disorders. 20: S101. DOI: 10.1097/00002093-200607001-00019  0.386
2006 Schmitt FA, Tariot PN, Grossberg GT, Hendrix S, Ellison N, Kerolous M. P2-002: SIB MAINTENANCE OF RESPONSE WITH MEMANTINE ADDED TO CHOLINESTERASE INHIBITORS: POOLED POST HOC ANALYSIS OF 2 RANDOMIZED CONTROLLED TRIALS IN PATIENTS WITH MODERATE TO SEVERE AD Alzheimer's & Dementia. 14: P665-P665. DOI: 10.1016/J.Jalz.2018.06.686  0.36
2006 Barber JM, Beech BF, Jicha GA, Caban-Holt AM, Schmitt FA. P1-506: CSF MARKERS OF PRECLINICAL ALZHEIMER'S AND DEFICITS ON A SELF-ADMINISTERED COMPUTERIZED TEST BATTERY Alzheimer's & Dementia. 14: P523-P524. DOI: 10.1016/J.Jalz.2018.06.517  0.337
2006 Mendiondo MS, Kryscio RJ, Schmitt FA, Core UC. P2-072: Antioxidant use at enrollment predicts transitions from normal to amnestic MCI and dementia Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.909  0.332
2006 Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Cooper G, Markesbery WR. IC-P-040: Structural image data from normals grouped by six-year cognitive outcome: MCI/AD conversion vs. normal Alzheimer's & Dementia. 2: S670-S671. DOI: 10.1016/J.Jalz.2006.05.2245  0.367
2006 Mendiondo MS, Caban-Holt AM, Saylor CR, Runyons C, Kryscio R, Markesbery WR, Schmitt FA. P3-007: Cognitive screening in the antioxidant AD prevention (PREADVISE) trial: Concordance of MIS and CERAD Alzheimer's & Dementia. 2: S373-S374. DOI: 10.1016/J.Jalz.2006.05.1274  0.394
2006 Scheff SW, Price DA, Schmitt FA, Schneider JA, Bennett DA, DeKosky ST, Mufson EJ. O1-01-01: Synaptic alterations in inferior temporal lobe in Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Alzheimer's & Dementia. 2: S7-S8. DOI: 10.1016/J.Jalz.2006.05.034  0.436
2005 Caban-Holt A, Bottiggi K, Schmitt FA. Measuring treatment response in Alzheimer's disease clinical trials. Geriatrics. 3-8. PMID 16025769  0.322
2005 Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 64: 1152-6. PMID 15824339 DOI: 10.1212/01.Wnl.0000156156.13641.Ba  0.317
2005 Schmitt FA, Mendiondo MS, Kryscio RJ, Ashford JW. [O1-05-05]: A Brief Alzheimer's screen for Use in clinical practice Alzheimer's & Dementia. 1: S89-S89. DOI: 10.1016/J.Jalz.2005.06.312  0.301
2005 Runyons CR, Schmitt FA, Caban-Holt A, Kryscio RJ, Mendiondo MS, Markesbery WR. [P-208]: Antioxidants for the prevention of dementia: Overview of the preadvise trial Alzheimer's & Dementia. 1: S74-S74. DOI: 10.1016/J.Jalz.2005.06.266  0.333
2005 Kryscio RJ, Salazar JC, Yu L, Mendiondo MS, Schmitt FA. [P-084]: Modeling clinical change from normal aging to MCI, dementia, and death Alzheimer's & Dementia. 1: S34-S34. DOI: 10.1016/J.Jalz.2005.06.158  0.358
2005 Schmitt FA, Markesbery WR, Kryscio RJ, Caban-Holt A, Cooper G, Smith C, Wekstein D, Davis DG. [P-032]: Neuropathological and memory changes in transitions between normal aging, MCI, and mild Alzheimer's disease Alzheimer's & Dementia. 1: S18-S19. DOI: 10.1016/J.Jalz.2005.06.094  0.399
2004 Kryscio RJ, Mendiondo MS, Schmitt FA, Markesbery WR. Designing a large prevention trial: statistical issues. Statistics in Medicine. 23: 285-96. PMID 14716729 DOI: 10.1002/Sim.1716  0.366
2004 Hoffmann M, Schmitt F. Cognitive impairment in isolated subtentorial stroke. Acta Neurologica Scandinavica. 109: 14-24. PMID 14653846 DOI: 10.1034/J.1600-0404.2003.00169.X  0.352
2004 van Dyck C, Cummings J, Schmitt F, Graham S, Olin J, Jin J, Tariot P. P4.028 Functional and behavioral effects of memantinein Alzheimer's disease European Neuropsychopharmacology. 14: S334-S335. DOI: 10.1016/S0924-977X(04)80452-8  0.359
2004 Schmitt F, Tariot P, Cummings J, Bell J, Jia D, Olin J. P4.021 Robust response to memantine treatmentwhen functional and behavioral results are combined with cognition European Neuropsychopharmacology. 14: S331. DOI: 10.1016/S0924-977X(04)80445-0  0.322
2004 Wirth Y, Doody R, Schmitt F, Moebius H, Stoeffler A. P4.011 Functional benefit of memantine treatment inpatients with moderate to severe Alzheimer's disease European Neuropsychopharmacology. 14: S327. DOI: 10.1016/S0924-977X(04)80435-8  0.38
2004 Wirth Y, Doody RS, Schmitt FA, Möbius HJ. P1-375 Functional benefits of memantine treatment for patients with moderate to severe Alzhemier's disease Neurobiology of Aging. 25: S205. DOI: 10.1016/S0197-4580(04)80687-0  0.327
2004 Cummings J, Dyck Cv, Schmitt F, Graham SM, Olin JT, Jin J, Tariot PN. P1-315 Functional and behavioral effects of memantine in Alzheimer's disease Neurobiology of Aging. 25: S186. DOI: 10.1016/S0197-4580(04)80628-6  0.361
2004 Schmitt FA, Tariot P, Cummings J, Bell J, Jia D, Olin J. P1-002 Robust response to memantine treatment when functional and behavioral efficacies are combined with cognition Neurobiology of Aging. 25: S93. DOI: 10.1016/S0197-4580(04)80316-6  0.318
2004 Schmitt FA, Estus S. Alzheimer's disease genetic susceptibility and causality: What is ApoE's impact? Neurobiology of Aging. 25: 661-662. DOI: 10.1016/J.Neurobiolaging.2004.02.008  0.346
2003 Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Designing a Brief Alzheimer Screen (BAS). Journal of Alzheimer's Disease : Jad. 5: 391-8. PMID 14646030 DOI: 10.3233/Jad-2003-5506  0.432
2003 Gaugler JE, Mendiondo M, Smith CD, Schmitt FA. Secondary dementia caregiving and its consequences. American Journal of Alzheimer's Disease and Other Dementias. 18: 300-8. PMID 14569647 DOI: 10.1177/153331750301800505  0.321
2003 Gaugler JE, Wackerbarth SB, Mendiondo M, Schmitt FA, Smith CD. The characteristics of dementia caregiving onset. American Journal of Alzheimer's Disease and Other Dementias. 18: 97-104. PMID 12708225 DOI: 10.1177/153331750301800208  0.318
2003 Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA, Markesbery WR. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 48-53. PMID 12707938 DOI: 10.1002/Ajmg.B.10069  0.404
2003 Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. The New England Journal of Medicine. 348: 1333-41. PMID 12672860 DOI: 10.1056/Nejmoa013128  0.303
2002 Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Möbius HJ, Stöffler A. Measuring cognition in advanced Alzheimer's disease for clinical trials. Journal of Neural Transmission. Supplementum. 135-48. PMID 12456059 DOI: 10.1007/978-3-7091-6139-5_14  0.359
2001 Schmitt FA, Wetherby MM, Wekstein DR, Dearth CM, Markesbery WR. Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. The Gerontologist. 41: 716-22. PMID 11723339 DOI: 10.1093/Geront/41.6.716  0.324
2001 Mendiondo MS, Kryscio RJ, Schmitt FA. Models of progression in AD: Predicting disability and costs Neurology. 57: 943-944. PMID 11571313 DOI: 10.1212/Wnl.57.6.943  0.377
2001 Ashford JW, Schmitt FA. Modeling the time-course of Alzheimer dementia. Current Psychiatry Reports. 3: 20-8. PMID 11177755 DOI: 10.1007/S11920-001-0067-1  0.435
2001 Johnson MMS, Wackerbarth SB, Schmitt FA. Revised Memory and Behavior Problems Checklist Clinical Gerontologist. 22: 87-108. DOI: 10.1300/J018V22N03_09  0.301
2000 Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology. 55: 370-6. PMID 10932270 DOI: 10.1212/Wnl.55.3.370  0.318
2000 Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Modelling mini mental state examination changes in Alzheimer's disease. Statistics in Medicine. 19: 1607-16. PMID 10844722 DOI: 10.1002/(Sici)1097-0258(20000615/30)19:11/12<1607::Aid-Sim449>3.0.Co;2-O  0.415
2000 Schmitt FA, Miller JP, Kryscio RJ. Promoting interactions with basic scientists and clinicians: summary of the panel session. Statistics in Medicine. 19: 1463-8. PMID 10844711 DOI: 10.1002/(Sici)1097-0258(20000615/30)19:11/12<1463::Aid-Sim438>3.0.Co;2-3  0.333
2000 Galasko DR, Schmitt FA, Jin S, Saxton J, Bennett D, Sano M, Ferris SH. Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 168. DOI: 10.1016/S0197-4580(00)82096-5  0.437
1999 Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology. 53: 1391-6. PMID 10534240 DOI: 10.1212/Wnl.53.7.1391  0.314
1999 Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. Journal of Neuropathology and Experimental Neurology. 58: 376-88. PMID 10218633 DOI: 10.1097/00005072-199904000-00008  0.304
1999 Saxe SR, Wekstein MW, Kryscio RJ, Henry RG, Cornett CR, Snowdon DA, Grant FT, Schmitt FA, Donegan SJ, Wekstein DR, Ehmann WD, Markesbery WR. Alzheimer's disease, dental amalgam and mercury. Journal of the American Dental Association (1939). 130: 191-9. PMID 10036842 DOI: 10.14219/Jada.Archive.1999.0168  0.355
1999 Smith CD, Malcein M, Meurer K, Schmitt FA, Markesbery WR, Pettigrew LC. MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 9: 2-9. PMID 9922716 DOI: 10.1111/Jon1999912  0.391
1997 Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ. The Severe Impairment Battery Alzheimer Disease & Associated Disorders. 11: 51-56. DOI: 10.1097/00002093-199700112-00008  0.414
1996 Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, Reisberg B, Schmitt FA. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. Journal of Geriatric Psychiatry and Neurology. 9: 176-80. PMID 8970010 DOI: 10.1177/089198879600900404  0.406
1996 Greiner PA, Snowdon DA, Schmitt FA. The loss of independence in activities of daily living: the role of low normal cognitive function in elderly nuns. American Journal of Public Health. 86: 62-6. PMID 8561244 DOI: 10.2105/Ajph.86.1.62  0.342
1996 Ashford JW, Schmitt FA, Kumar V. Diagnosis of Alzheimer's Disease Psychiatric Annals. 26: 262-268. DOI: 10.3928/0048-5713-19960501-06  0.378
1995 Ashford JW, Shan M, Butler S, Rajasekar A, Schmitt FA. Temporal quantification of Alzheimer's disease severity: 'time index' model. Dementia (Basel, Switzerland). 6: 269-80. PMID 8528374 DOI: 10.1159/000106958  0.422
1994 Marson DC, Schmitt FA, Ingram KK, Harrell LE. Determining the competency of Alzheimer patients to consent to treatment and research. Alzheimer Disease and Associated Disorders. 8: 5-18. PMID 7695856 DOI: 10.1097/00002093-199400000-00002  0.374
1994 Blonder LX, Kort ED, Schmitt FA. Conversational Discourse in Patients with Alzheimer's Disease Journal of Linguistic Anthropology. 4: 50-71. DOI: 10.1525/Jlin.1994.4.1.50  0.335
1993 Logue PE, Tupler LA, D'Amico CJ, Schmitt FA. The Neurobehavioral Cognitive Status Examination: psychometric properties in use with psychiatric inpatients. Journal of Clinical Psychology. 49: 80-89. PMID 8425938 DOI: 10.1002/1097-4679(199301)49:1<80::Aid-Jclp2270490111>3.0.Co;2-Z  0.379
1993 Lanska DJ, Schmitt FA, Stewart JM, Howe JN. Telephone-Assessed Mental State. Dementia (Basel, Switzerland). 4: 117-9. PMID 8358512 DOI: 10.1159/000107307  0.381
1992 DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesbery WR. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Annals of Neurology. 32: 625-32. PMID 1360195 DOI: 10.1002/Ana.410320505  0.409
1992 Schmitt FA, Shih W, DeKosky ST. Neuropsychological correlates of single photon emission computed tomography (SPECT) in Alzheimer's disease. Neuropsychology. 6: 159-171. DOI: 10.1037/0894-4105.6.2.159  0.305
1991 Berry DT, Allen RS, Schmitt FA. Rey-Osterrieth complex figure: Psychometric characteristics in a geriatric sample Clinical Neuropsychologist. 5: 143-153. DOI: 10.1080/13854049108403298  0.335
1990 DeKosky ST, Shih WJ, Schmitt FA, Coupal J, Kirkpatrick C. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: correlation with cognitive severity. Alzheimer Disease and Associated Disorders. 4: 14-23. PMID 2317335 DOI: 10.1097/00002093-199040100-00002  0.419
1989 Schmitt FA, Ranseen JD, DeKosky ST. Cognitive Mental Status Examinations Clinics in Geriatric Medicine. 5: 545-564. DOI: 10.1016/S0749-0690(18)30670-0  0.328
1989 Schmitt F. Neuropsychological correlates of Single Photon Emission Tomography (SPECT) in Alzheimer's disease Archives of Clinical Neuropsychology. 4: 117. DOI: 10.1016/0887-6177(89)90067-X  0.32
1988 Farber JF, Schmitt FA, Logue PE. Predicting intellectual level from the Mini-Mental State Examination. Journal of the American Geriatrics Society. 36: 509-10. PMID 3372930 DOI: 10.1111/J.1532-5415.1988.Tb04020.X  0.346
1988 Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. The New England Journal of Medicine. 319: 1573-8. PMID 3059187 DOI: 10.1056/Nejm198812153192404  0.348
Low-probability matches (unlikely to be authored by this person)
2009 Schmitt F, Farlow M, Olin J, Meng X. P1.038 Rivastigmine treatment effects and the relationship between executive function and cognition, behavior and ADLs in Parkinson's disease dementia Parkinsonism & Related Disorders. 15: S38. DOI: 10.1016/S1353-8020(09)70160-9  0.298
1997 Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) Alzheimer Disease & Associated Disorders. 11: 425-429. DOI: 10.1007/978-1-4612-4116-4_64  0.297
2017 Helman AM, Murphy P, McCarty K, Schmitt FA, Head E. [P4-275]: CEREBRAL AMYLOID ANGIOPATHY AND MICROHEMORRHAGES IN THE OCCIPITAL CORTEX OF AGING ADULTS WITH DOWN SYNDROME Alzheimer's & Dementia. 13: P1390-P1391. DOI: 10.1016/J.Jalz.2017.06.2144  0.294
2005 Caban-Holt A, Mattingly M, Cooper G, Schmitt FA. Neurodegenerative memory disorders: A potential role of environmental toxins Neurologic Clinics. 23: 485-521. PMID 15757794 DOI: 10.1016/J.Ncl.2004.12.005  0.293
2018 Head E, Powell DK, Schmitt FA. Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis. Frontiers in Aging Neuroscience. 10: 191. PMID 29977201 DOI: 10.3389/fnagi.2018.00191  0.293
2013 Blonder LX, Slevin JT, Kryscio RJ, Martin CA, Andersen AH, Smith CD, Schmitt FA. Dopaminergic modulation of memory and affective processing in Parkinson depression. Psychiatry Research. 210: 146-9. PMID 23838419 DOI: 10.1016/J.Psychres.2013.06.003  0.293
2009 Andersen A, Slevin J, Smith C, Kryscio R, Schmitt F, Martin C, Blonder L. Neuroimaging of Verbal Working Memory in Parkinson's disease Neuroimage. 47. DOI: 10.1016/S1053-8119(09)70981-4  0.292
2006 Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology. 66: 828-32. PMID 16567698 DOI: 10.1212/01.Wnl.0000203264.71880.45  0.292
1980 Sanders RE, Murphy MD, Schmitt FA, Walsh KK. Age differences in free recall rehearsal strategies. Journal of Gerontology. 35: 550-8. PMID 7400548 DOI: 10.1093/Geronj/35.4.550  0.291
2021 Harp JP, Koehl LM, Pelt KLV, Hom CL, Doran E, Head E, Lott IT, Schmitt FA. Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome. Brain Sciences. 11. PMID 34573150 DOI: 10.3390/brainsci11091128  0.29
2009 Hoffmann M, Schmitt F, Bromley E. Vascular cognitive syndromes: relation to stroke etiology and topography. Acta Neurologica Scandinavica. 120: 161-9. PMID 19486324 DOI: 10.1111/J.1600-0404.2008.01145.X  0.288
2005 Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer. 104: 2499-507. PMID 16247788 DOI: 10.1002/Cncr.21482  0.288
2016 Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, Cairns NJ, Yu L, Dodge HH, Xiong C, Masaki K, Tyas SL, Bennett DA, Schneider JA, Arvanitakis Z. Diabetes is associated with cerebrovascular but not Alzheimer neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26812281 DOI: 10.1016/J.Jalz.2015.12.006  0.287
1990 Berry DT, Phillips BA, Cook YR, Schmitt FA, Honeycutt NA, Arita AA, Allen RS. Geriatric sleep apnea syndrome: a preliminary description. Journal of Gerontology. 45: M169-74. PMID 2394913 DOI: 10.1093/Geronj/45.5.M169  0.286
2004 Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Bales RA, Ethisham A, Greenberg RN, Berger JR. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. Journal of Neurovirology. 10: 223-32. PMID 15371152 DOI: 10.1080/13550280490463532  0.286
2020 Martini AC, Helman AM, McCarty KL, Lott IT, Doran E, Schmitt FA, Head E. Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12113. PMID 33088896 DOI: 10.1002/dad2.12113  0.285
2006 Cragar DE, Berry DT, Fakhoury TA, Cibula JE, Schmitt FA. Performance of patients with epilepsy or psychogenic non-epileptic seizures on four measures of effort. The Clinical Neuropsychologist. 20: 552-66. PMID 16895866 DOI: 10.1080/13854040590947380  0.285
2013 Nelson P, Abner E, Smith C, Jicha G, Kryscio R, Fardo D, Neltner J, Van Eldik L, Schmitt F. P4-186: Clinical correlates of hippocampal sclerosis of aging: The University of Kentucky experience Alzheimer's & Dementia. 9: P773-P773. DOI: 10.1016/J.Jalz.2013.05.1577  0.285
1997 Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimerʼs Disease Clinical Trials Alzheimer Disease & Associated Disorders. 11: 1-12. DOI: 10.1097/00002093-199700112-00002  0.284
1989 Johnson MM, Schmitt FA, Pietrukowicz M. The memory advantages of the generation effect: age and process differences. Journal of Gerontology. 44: P91-4. PMID 2715591 DOI: 10.1093/Geronj/44.3.P91  0.283
1998 Piecoro LT, Wermeling DP, Schmitt FA, Ashford JW. Seizures in patients receiving concomitant antimuscarinics and acetylcholinesterase inhibitor. Pharmacotherapy. 18: 1129-1132. DOI: 10.1002/J.1875-9114.1998.Tb03944.X  0.282
2021 DiProspero ND, Keator DB, Phelan M, van Erp TGM, Doran E, Powell DK, Van Pelt KL, Schmitt FA, Head E, Lott IT, Yassa MA. Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome. Journal of Alzheimer's Disease : Jad. PMID 34776436 DOI: 10.3233/JAD-210572  0.282
1992 Dickson LR, Hays LR, Kaplan C, Scherl E, Abbott S, Schmitt F. Psychological profile of somatizing patients attending the integrative clinic International Journal of Psychiatry in Medicine. 22: 141-153. PMID 1517021 DOI: 10.2190/Mq3B-B9Ju-18Wm-Ecuh  0.281
1989 Macciocchi SN, Ranseen JD, Schmitt FA. The relationship between neuropsychological impairment in alcoholics and treatment outcome at one year. Archives of Clinical Neuropsychology. 4: 365-370. DOI: 10.1016/0887-6177(89)90026-7  0.28
1981 Murphy MD, Sanders RE, Gabriesheski AS, Schmitt FA. Metamemory in the aged. Journal of Gerontology. 36: 185-93. PMID 7193705 DOI: 10.1093/Geronj/36.2.185  0.279
2018 Frank L, Wesson Ashford J, Bayley P, Borson S, Buschke H, Cohen D, Cummings JL, Davies P, Dean M, Finkel SI, Hyer L, Perry G, Powers RE, Schmitt F. Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle. Journal of Alzheimer's Disease : Jad. PMID 30282369 DOI: 10.3233/Jad-180629  0.279
2008 Jicha GA, Abner E, Schmitt FA, Cooper GE, Stiles N, Hamon R, Carr S, Smith CD, Markesbery WR. Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings. Dementia and Geriatric Cognitive Disorders. 26: 187-92. PMID 18724049 DOI: 10.1159/000151635  0.279
2007 Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 68: 1501-8. PMID 17470753 DOI: 10.1212/01.Wnl.0000260698.46517.8F  0.278
2004 Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR. Neuroimaging correlates of HIV-associated BBB compromise. Journal of Neuroimmunology. 157: 140-6. PMID 15579291 DOI: 10.1016/J.Jneuroim.2004.08.025  0.276
1997 Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S22-32. PMID 9236949 DOI: 10.1097/00002093-199700112-00004  0.275
1989 Berry DT, Phillips BA, Cook YR, Schmitt FA, Honeycutt NA, Edwards CL, Lamb DG, Magan LK, Allen RS. Sleep-disordered breathing in healthy aged persons: one-year follow-up of daytime sequelae. Sleep. 12: 211-5. PMID 2740692 DOI: 10.1093/Sleep/12.3.211  0.275
1992 Phillips BA, Berry DTR, Schmitt FA, Magan LK, Gerhardstein DC, Cook YR. Sleep-disordered breathing in the healthy elderly; Clinically significant? Chest. 101: 345-349. PMID 1735252 DOI: 10.1378/Chest.101.2.345  0.274
1981 Schmitt FA, Murphy MD, Sanders RE. Training older adult free recall rehearsal strategies. Journal of Gerontology. 36: 329-37. PMID 7229280 DOI: 10.1093/Geronj/36.3.329  0.274
2018 Richards AG, Tietyen AC, Jicha GA, Bardach SH, Schmitt FA, Fardo DW, Kryscio RJ, Abner EL. Visual Arts Education improves self-esteem for persons with dementia and reduces caregiver burden: A randomized controlled trial. Dementia (London, England). 1471301218769071. PMID 29653492 DOI: 10.1177/1471301218769071  0.274
2019 Van Pelt K, McCarty K, Davis R, Lykins J, Jicha GA, Caban-Holt AM, Lighner D, Robertson W, Brothers S, Lin A, Powell DK, Head E, Schmitt FA. P3-405: AGING IN DOWN SYNDROME: AGE-ASSOCIATED BRAIN METABOLITE CHANGES Alzheimer's & Dementia. 15: P1109-P1109. DOI: 10.1016/J.Jalz.2019.06.3439  0.272
2006 Locke DE, Berry DT, Fakhoury TA, Schmitt FA. Relationship of indicators of neuropathology, psychopathology, and effort to neuropsychological results in patients with epilepsy or psychogenic non-epileptic seizures. Journal of Clinical and Experimental Neuropsychology. 28: 325-40. PMID 16618623 DOI: 10.1080/13803390490918183  0.272
1992 Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Henslee-Downey PJ. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer. 70: 2288-97. PMID 1394058 DOI: 10.1002/1097-0142(19921101)70:9<2288::Aid-Cncr2820700913>3.0.Co;2-M  0.271
2004 Gaugler JE, Anderson KA, Leach MS, Smith CD, Schmitt FA, Mendiondo M. The emotional ramifications of unmet need in dementia caregiving. American Journal of Alzheimer's Disease and Other Dementias. 19: 369-80. PMID 15633946 DOI: 10.1177/153331750401900605  0.27
1987 Berry DT, Phillips BA, Cook YR, Schmitt FA, Gilmore RL, Patel R, Keener TM, Tyre E. Sleep-disordered breathing in healthy aged persons: possible daytime sequelae. Journal of Gerontology. 42: 620-6. PMID 3680881 DOI: 10.1093/Geronj/42.6.620  0.267
2020 Winder Z, Lee T, Fardo DW, Cheng Q, Goldstein L, Nelson PT, Schmitt FA, Jicha GA, Wilcock DM. Evaluating vascular cognitive impairment and dementia due to small‐vessel disease using plasma levels of PLGF and VEGF‐A Alzheimer's & Dementia. 16. DOI: 10.1002/alz.044576  0.267
1999 Blonder LX, Hodes JE, Ranseen JD, Schmitt FA. Short-term neuropsychological outcome following Gamma Knife radiosurgery for arteriovenous malformations: a preliminary report. Applied Neuropsychology. 6: 181-6. PMID 10497695 DOI: 10.1207/S15324826An0603_7  0.266
2001 Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR. Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology. 7: 66-71. PMID 11519485 DOI: 10.1080/135502801300069737  0.265
1992 Schmitt F, De Kosky S, Shih W. Single positron emission tomography (SPECT) correlates of cognitive and behavioral dysfunction in Alzheimer's disease European Neuropsychopharmacology. 2: 322. DOI: 10.1016/0924-977X(92)90164-4  0.261
2019 Pettigrew C, Brichko R, Black B, O'Connor MK, Austrom MG, Robinson MT, Lindauer A, Shah RC, Peavy GM, Meyer K, Schmitt FA, Lingler JH, Domoto-Reilly K, Farrar-Edwards D, Albert M. Attitudes toward advance care planning among persons with dementia and their caregivers. International Psychogeriatrics. 1-15. PMID 31309906 DOI: 10.1017/S1041610219000784  0.26
1998 Pettigrew LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR, Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski B. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease. Journal of Clinical Pharmacology. 38: 236-45. PMID 9549662 DOI: 10.1002/J.1552-4604.1998.Tb04421.X  0.26
2021 Karanth SD, Schmitt FA, Nelson PT, Katsumata Y, Kryscio RJ, Fardo DW, Harp JP, Abner EL. Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies. Journal of Alzheimer's Disease : Jad. PMID 34057090 DOI: 10.3233/JAD-210293  0.259
2006 Nelson KR, Mattingly M, Lee SA, Schmitt FA. Does the arousal system contribute to near death experience? Neurology. 66: 1003-9. PMID 16606911 DOI: 10.1212/01.Wnl.0000204296.15607.37  0.258
2020 Koehl L, Harp J, Van Pelt KL, Head E, Schmitt FA. Longitudinal assessment of dementia measures in Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12075. PMID 33225040 DOI: 10.1002/dad2.12075  0.256
2022 Harp J, Koehl L, Van Pelt K, Head E, Jicha G, Robertson W, Lightner D, Lott I, Schmitt F. Primitive Reflexes and Dementia in Adults With Down Syndrome. Neurology. Clinical Practice. 12: 6-13. PMID 36157622 DOI: 10.1212/CPJ.0000000000001135  0.254
1994 Phillips BA, Berry DTR, Schmitt FA, Harbison L, Lipke-Molby T. Sleep-disordered breathing in healthy aged persons: Two- and three-year follow-up Sleep. 17: 411-415. PMID 7991951 DOI: 10.1093/Sleep/17.5.411  0.253
1997 Forrest DA, Schmitt FA, Wekstein D, Markesbery W. Speed and memory correlates of digit symbol recall performance in older adults Archives of Clinical Neuropsychology. 12: 318-318. DOI: 10.1093/Arclin/12.4.318  0.252
2015 Andersen AH, Smith CD, Slevin JT, Kryscio RJ, Martin CA, Schmitt FA, Blonder LX. Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression. Parkinson's Disease. 2015: 513452. PMID 26793404 DOI: 10.1155/2015/513452  0.251
2006 Abner EL, Nelson PT, Jicha GA, Fardo DW, Schmitt FA, Kryscio RJ. P2-610: CIGARETTE SMOKING AND RISK OF DEMENTIA IN A KENTUCKY COHORT: A COMPETING RISK ANALYSIS Alzheimer's & Dementia. 14: P973-P973. DOI: 10.1016/J.Jalz.2018.06.1306  0.251
2017 Fontaine SN, Ingram A, Cloyd RA, Meier SE, Miller E, Lyons D, Nation GK, Mechas E, Weiss B, Lanzillotta C, Di Domenico F, Schmitt F, Powell DK, Vandsburger M, Abisambra JF. Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach. Neurobiology of Aging. 56: 78-86. PMID 28500878 DOI: 10.1016/J.Neurobiolaging.2017.04.007  0.25
2015 Downer B, Fardo DW, Schmitt FA. A Summary Score for the Framingham Heart Study Neuropsychological Battery. Journal of Aging and Health. PMID 25804903 DOI: 10.1177/0898264315577590  0.249
2020 Winder Z, Sudduth TL, Fardo D, Cheng Q, Goldstein LB, Nelson PT, Schmitt FA, Jicha GA, Wilcock DM. Hierarchical Clustering Analyses of Plasma Proteins in Subjects With Cardiovascular Risk Factors Identify Informative Subsets Based on Differential Levels of Angiogenic and Inflammatory Biomarkers. Frontiers in Neuroscience. 14: 84. PMID 32116527 DOI: 10.3389/Fnins.2020.00084  0.248
1987 Murphy MD, Schmitt FA, Caruso MJ, Sanders RE. Metamemory in older adults: The role of monitoring in serial recall. Psychology and Aging. 2: 331-339. DOI: 10.1037//0882-7974.2.4.331  0.247
2015 Jenkins A, Bayer A, Tree J, Tales A, Schmitt FA, Abner E, Kryscio R. Self-reported memory complaints: Implications from a longitudinal cohort with autopsies. Neurology. 84: 2384. PMID 26054896 DOI: 10.1212/Wnl.0000000000001677  0.246
2011 Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ. Vitamin E and all-cause mortality: a meta-analysis. Current Aging Science. 4: 158-70. PMID 21235492 DOI: 10.2174/1874609811104020158  0.246
2004 Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC, Gore EM, Franklin RL, Suh JH, Mehta MP. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018. International Journal of Radiation Oncology, Biology, Physics. 58: 1346-52. PMID 15050309 DOI: 10.1016/J.Ijrobp.2003.09.023  0.246
1990 Phillips BA, Schmitt FA, Berry DT, Lamb DG, Amin M, Cook YR. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest. 98: 325-30. PMID 2198135 DOI: 10.1378/Chest.98.2.325  0.245
2005 Smith CD, Kryscio RJ, Schmitt FA, Lovell MA, Blonder LX, Rayens WS, Andersen AH. Longitudinal functional alterations in asymptomatic women at risk for Alzheimer's disease Journal of Neuroimaging. 15: 271-277. PMID 15951411 DOI: 10.1111/J.1552-6569.2005.Tb00321.X  0.244
2023 Karr JE, Hakun JG, Elbich DB, Pinheiro CN, Schmitt FA, Segerstrom SC. Detecting cognitive decline in high-functioning older adults: The relationship between subjective cognitive concerns, frequency of high neuropsychological test scores, and the frontoparietal control network. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 37750195 DOI: 10.1017/S1355617723000607  0.243
2005 Cragar DE, Berry DT, Schmitt FA, Fakhoury TA. Cluster analysis of normal personality traits in patients with psychogenic nonepileptic seizures. Epilepsy & Behavior : E&B. 6: 593-600. PMID 15907754 DOI: 10.1016/J.Yebeh.2005.03.007  0.241
1988 Cook Y, Schmitt F, Berry D, Phillips B, Gilmore R. Periodic Movements of Sleep (Nocturnal Myoclonus) in Healthy Aged Adults Journal of Clinical Neurophysiology. 5: 354. DOI: 10.1097/00004691-198810000-00082  0.24
2010 Locke DE, Fakhoury TA, Berry DT, Locke TR, Schmitt FA. Objective evaluation of personality and psychopathology in temporal lobe versus extratemporal lobe epilepsy. Epilepsy & Behavior : E&B. 17: 172-7. PMID 20022813 DOI: 10.1016/J.Yebeh.2009.11.005  0.239
2017 Head E, Helman A, Powell D, Schmitt F. Down syndrome, beta-amyloid and neuroimaging. Free Radical Biology & Medicine. PMID 28935420 DOI: 10.1016/j.freeradbiomed.2017.09.013  0.239
1994 Berry DTR, Carpenter GS, Campbell DA, Schmitt FA, Helton K, Lipke-Molby T. The New Adult Reading Test-Revised: accuracy in estimating WAIS-R IQ scores obtained 3.5 years earlier from normal older persons. Archives of Clinical Neuropsychology. 9: 239-250. DOI: 10.1093/Arclin/9.3.239  0.236
2020 Blevins BL, Vinters HV, Love S, Wilcock DM, Grinberg LT, Schneider JA, Kalaria RN, Katsumata Y, Gold BT, Wang DJJ, Ma SJ, Shade LMP, Fardo DW, Hartz AMS, Jicha GA, ... ... Schmitt FA, et al. Brain arteriolosclerosis. Acta Neuropathologica. PMID 33098484 DOI: 10.1007/s00401-020-02235-6  0.236
2007 Nelson KR, Mattingly M, Schmitt FA. Out-of-body experience and arousal. Neurology. 68: 794-5. PMID 17339596 DOI: 10.1212/01.Wnl.0000256784.85952.6F  0.235
2014 Shandera-Ochsner AL, Han DY, Rose D, Aroor SR, Schmitt F, Bellamy LM, Dobbs MR. Comparing the trends of elevated blood pressure in appalachian and non-Appalachian regions. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 713-5. PMID 25132199 DOI: 10.1111/Jch.12397  0.233
1989 Phillips B, Berry D, Schmitt F, Patel R, Cook Y. Sleep quality and pulmonary function in the healthy elderly. Chest. 95: 60-4. PMID 2909357 DOI: 10.1378/Chest.95.1.60  0.232
2006 Caban-Holt A, Mendiondo MS, Markesbery WR, Kryscio R, Schmitt F. Minority Participation in the PREADVISE Trial: Relevant Characteristics Alzheimer Disease & Associated Disorders. 20: S101. DOI: 10.1097/00002093-200607001-00021  0.232
1993 Van Gorp WG, Lamb DG, Schmitt FA. Methodologic issues in neuropsychological research with HIV-spectrum disease. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 8: 17-33. PMID 14589588 DOI: 10.1016/0887-6177(93)90040-8  0.23
2019 Barber JM, Jicha GA, Hill E, Schmitt FA. P1-451: WITHIN-SESSION LEARNING OF AN OBJECT IDENTIFICATION TASK PREDICTS ELEVATED BRAIN AMYLOID AND FUTURE TASK PERFORMANCE Alzheimer's & Dementia. 15: P439-P440. DOI: 10.1016/J.Jalz.2019.06.1056  0.23
2003 Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius H, Vinyoles E. La memantina podría frenar el deterioro clínico de los pacientes con enfermedad de Alzheimer de moderada a avanzada Fmc - FormacióN MéDica Continuada En AtencióN Primaria. 10: 597. DOI: 10.1016/S1134-2072(03)76016-2  0.23
2000 Karlawish JH, Schmitt FA. Why physicians need to become more proficient in assessing their patients' competency and how they can achieve this. Journal of the American Geriatrics Society. 48: 1014-6. PMID 10968311 DOI: 10.1111/J.1532-5415.2000.Tb06904.X  0.227
2019 Ding X, Charnigo RJ, Schmitt FA, Kryscio RJ, Abner EL. Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI. Plos One. 14: e0212435. PMID 30802256 DOI: 10.1371/Journal.Pone.0212435  0.227
2002 Cragar DE, Berry DT, Fakhoury TA, Cibula JE, Schmitt FA. A review of diagnostic techniques in the differential diagnosis of epileptic and nonepileptic seizures. Neuropsychology Review. 12: 31-64. PMID 12090718 DOI: 10.1023/A:1015491123070  0.227
1986 Mitchell DB, Hunt RR, Schmitt FA. The generation effect and reality monitoring: evidence from dementia and normal aging. Journal of Gerontology. 41: 79-84. PMID 3941260 DOI: 10.1093/geronj/41.1.79  0.224
2006 Schmitt FA, Grossberg GT, Tariot PN, Hendrix S, Ellison N, Kerolous M. P1-052: EFFICACY OF MEMANTINE ADDED TO CHOLINESTERASE INHIBITORS ON SIB BEHAVIORAL DOMAINS: POOLED POST HOC ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS IN PATIENTS WITH MODERATE TO SEVERE AD Alzheimer's & Dementia. 14: P287-P288. DOI: 10.1016/j.jalz.2018.06.054  0.224
2015 Bayley PJ, Kong JY, Mendiondo M, Lazzeroni LC, Borson S, Buschke H, Dean M, Fillit H, Frank L, Schmitt FA, Peschin S, Finkel S, Austen M, Steinberg C, Ashford JW. Findings from the National Memory Screening Day program. Journal of the American Geriatrics Society. 63: 309-14. PMID 25643739 DOI: 10.1111/Jgs.13234  0.223
2003 Cragar DE, Schmitt FA, Berry DT, Cibula JE, Dearth CM, Fakhoury TA. A comparison of MMPI-2 decision rules in the diagnosis of nonepileptic seizures. Journal of Clinical and Experimental Neuropsychology. 25: 793-804. PMID 13680457 DOI: 10.1076/Jcen.25.6.793.16471  0.223
2010 Schmitt F, Thomason P. William R. Markesbery, MD (1932-2010) Neurology. 75: 20-20. DOI: 10.1212/Wnl.0B013E3181E73343  0.223
2006 Hoffmann M, Schmitt F. Metacognition in Stroke: Bedside Assessment and Relation to Location, Size, and Stroke Severity Cognitive and Behavioral Neurology. 19: 85-94. PMID 16783131 DOI: 10.1097/01.Wnn.0000213903.59827.50  0.222
2007 Kwok Y, Won M, Regine W, Mehta M, Schmitt F, Patchell R, Watkins-Bruner D. Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018 International Journal of Radiation Oncology*Biology*Physics. 69: S103. DOI: 10.1016/J.Ijrobp.2007.07.189  0.221
2021 Carmona-Iragui M, Alcolea D, Barroeta I, Videla L, Muñoz L, Van Pelt KL, Schmitt FA, Lightner DD, Koehl LM, Jicha G, Sacco S, Mircher C, Pape SE, Hithersay R, Clare ICH, et al. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. The Lancet. Neurology. 20: 605-614. PMID 34302785 DOI: 10.1016/S1474-4422(21)00129-0  0.22
1996 Raguet ML, Campbell DA, Berry DTR, Schmitt FA, Smith GT. Stability of intelligence and intellectual predictors in older persons Psychological Assessment. 8: 154-160. DOI: 10.1037//1040-3590.8.2.154  0.215
1997 Campbell DA, Ranseen JD, Schmitt FA. Evaluation of personality change following traumatic brain injury using the NEO-PI-R Archives of Clinical Neuropsychology. 12: 295-295. DOI: 10.1093/Arclin/12.4.295A  0.213
2019 Hendrix J, Burke AD, Capone G, Chicoine B, Costa A, Esbensen AJ, Hart SJ, Head E, Kishnani PS, Lai F, Lott IT, Ochoa-Lubinoff C, Rosas HD, Rosser T, Santoro SL, ... Schmitt FA, et al. P2-030: THE LIFE-DSR STUDY Alzheimer's & Dementia. 15: P582-P583. DOI: 10.1016/J.Jalz.2019.06.1252  0.212
1997 Blonder L, Hodes J, Schmitt F, Ranseen J, Kirkpatrick A. Neuropsychological outcome following Gamma Knife radiosurgery for arteriovenous malformations Archives of Clinical Neuropsychology. 12: 289-289. DOI: 10.1093/Arclin/12.4.289  0.21
1988 Cook YR, Gilmore R, Berry DRT, Schmitt F, Phillips BA, Patel R, Keener T. THE MULTIPLE SLEEP LATENCY TEST Journal of Clinical Neurophysiology. 5: 202. DOI: 10.1097/00004691-198804000-00040  0.206
2019 Abner EL, Nelson PT, Jicha GA, Cooper GE, Fardo DW, Schmitt FA, Kryscio RJ. Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis. Journal of Alzheimer's Disease : Jad. PMID 30856115 DOI: 10.3233/Jad-181119  0.2
2002 Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ. Women at risk for AD show increased parietal activation during a fluency task. Neurology. 58: 1197-202. PMID 11971086 DOI: 10.1212/Wnl.58.8.1197  0.198
2021 Wallace ER, Segerstrom SC, van Horne CG, Schmitt FA, Koehl LM. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression. Neuropsychology Review. PMID 33860906 DOI: 10.1007/s11065-021-09502-7  0.193
2023 Bachstetter AD, Lutshumba J, Winford E, Abner EL, Martin BJ, Harp JP, Van Eldik LJ, Schmitt FA, Wilcock DM, Stowe AM, Jicha GA, Nikolajczyk BS. A blunted T17 cytokine signature in women with mild cognitive impairment: insights from inflammatory profiling of a community-based cohort of older adults. Brain Communications. 5: fcad259. PMID 37901041 DOI: 10.1093/braincomms/fcad259  0.191
2021 Wang P, Abner EL, Fardo DW, Schmitt FA, Jicha GA, Van Eldik LJ, Kryscio RJ. Reduced rank multinomial logistic regression in Markov chains with application to cognitive data. Statistics in Medicine. PMID 33694178 DOI: 10.1002/sim.8923  0.191
2023 Ighodaro ET, Shahidehpour RK, Bachstetter AD, Abner EL, Nelson RS, Fardo DW, Shih AY, Grant RI, Neltner JH, Schmitt FA, Jicha GA, Kryscio RJ, Wilcock DM, Van Eldik LJ, Nelson PT. A neuropathologic feature of brain aging: multi-lumen vascular profiles. Acta Neuropathologica Communications. 11: 138. PMID 37641147 DOI: 10.1186/s40478-023-01638-2  0.188
2006 Reisberg B, Doody R, Schmitt F, Ferris S. Open-Label Extension Studies and Misinformation—Reply Archives of Neurology. 63: 1036. DOI: 10.1001/Archneur.63.7.1036-B  0.186
2003 Moebius H, Reisberg B, Schmitt F, Doody R. P.4.006 Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease European Neuropsychopharmacology. 13: S388-S389. DOI: 10.1016/S0924-977X(03)92201-2  0.177
2020 Smith CD, Van Eldik LJ, Jicha GA, Schmitt FA, Nelson PT, Abner EL, Kryscio RJ, Murphy RR, Andersen AH. Brain structure changes over time in normal and mildly impaired aged persons. Aims Neuroscience. 7: 120-135. PMID 32607416 DOI: 10.3934/Neuroscience.2020009  0.168
2014 Song I, Chung Y, Chung S, Huang W, Tseng C, Lin C, Lin C, Sung F, Kao C, Rosvik J, Engedal K, Kirkevold Ø, Sayad A, Noruzinia M, Abner EL, ... ... Schmitt FA, et al. Contents Vol. 37, 2014 Dementia and Geriatric Cognitive Disorders. 37. DOI: 10.1159/000363783  0.167
2017 Jiang Y, Lin MK, Jicha GA, Ding X, McIlwrath SL, Fardo DW, Broster LS, Schmitt FA, Kryscio R, Lipsky RH. Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adults. Aging. PMID 28439047 DOI: 10.18632/aging.101228  0.162
1986 Schultz KA, Schmitt FA, Logue PE, Rubin DC. Unit Analysis of Prose Memory in Clinical and Elderly Populations Developmental Neuropsychology. 2: 77-87. DOI: 10.1080/87565648609540331  0.155
1997 Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. Multicenter Evaluation of New Instruments for Alzheimerʼs Disease Clinical Trials Alzheimer Disease & Associated Disorders. 11: 65-69. DOI: 10.1097/00002093-199700112-00010  0.152
1994 Schmitt FA. An Introduction to Neuropsychology and Aging Contemporary Psychology: a Journal of Reviews. 39: 388-389. DOI: 10.1037/034087  0.126
1991 Fletcher JM, Francis DJ, Pequegnat W, Raudenbush SW, Bornstein MH, Schmitt F, Brouwers P, Stover E. Neurobehavioral outcomes in diseases of childhood. Individual change models for pediatric human immunodeficiency viruses. The American Psychologist. 46: 1267-77. PMID 1801614 DOI: 10.1037//0003-066X.46.12.1267  0.112
2017 Head E, LeVine H, Spielmann HP, Matveev S, Cauvi FM, Murphy P, Beckett T, McCarty K, Lott IT, Doran E, Schmitt FA. [P1-458]: DOWN SYNDROME: AGE-DEPENDENCE OF PIB BINDING IN POSTMORTEM FRONTAL CORTEX ACROSS THE LIFESPAN Alzheimer's & Dementia. 13: P462-P462. DOI: 10.1016/j.jalz.2017.06.474  0.109
1999 Smith CD, Umberger GH, Manning EL, Slevin JT, Wekstein DR, Schmitt FA, Markesbery WR, Zhang Z, Gerhardt GA, Kryscio RJ, Gash DM. Critical decline in fine motor hand movements in human aging. Neurology. 53: 1458-61. PMID 10534251 DOI: 10.1212/Wnl.53.7.1458  0.104
2011 Dennis BC, Houff SA, Han DY, Schmitt FA. Development of neurocognitive disorders in HIV/AIDS Neurobehavioral Hiv Medicine. 3: 9-18. DOI: 10.2147/NBHIV.S7170  0.102
2015 Kryscio RJ, Abner EL, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Lou W, Fardo DW, Cooper GE, Schmitt FA. P1-114: Self-reported memory complaints: A comparison of demented and unimpaired outcomes Alzheimer's & Dementia. 11: P383-P384. DOI: 10.1016/j.jalz.2015.06.312  0.095
2021 Gera G, Guduru Z, Yamasaki T, Gurwell JA, Chau MJ, Krotinger A, Schmitt FA, Slevin JT, Gerhardt GA, van Horne C, Quintero JE. Gait and Balance Changes with Investigational Peripheral Nerve Cell Therapy during Deep Brain Stimulation in People with Parkinson's Disease. Brain Sciences. 11. PMID 33921079 DOI: 10.3390/brainsci11040500  0.081
2001 Smith CD, Andersen AH, Kryscio RJ, Schmitt FA, Kindy MS, Blonder LX, Avison MJ. Differences in functional magnetic resonance imaging activation by category in a visual confrontation naming task. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 11: 165-70. PMID 11296587 DOI: 10.1111/J.1552-6569.2001.Tb00028.X  0.071
1996 Clavert A, Cranz C, Gathrat J, Hachette D, Marx D, Schmitt F. Analyse des procédures du test de Hühner ou test postcoïtal tel qu'il est pratiqué en région Alsace Andrologie. 6: 224-227. DOI: 10.1007/BF03034452  0.031
2007 Nelson KR, Mattingly M, Schmitt FA. Out-of-body experience and arousal Neurology. 68: 794-795. DOI: 10.1212/01.wnl.0000256784.85952.6f  0.016
2015 Schmitt FA, Abner E, Kryscio R. Author Response. Neurology. 84: 2384. PMID 26251864  0.01
Hide low-probability matches.